Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1708527 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.91Day +2.84%Mkt cap $42MP/E (FY) 1.0×1Y −53.8%Off 52W high −63.8%Vol (1Y) 78.1%
Daily closing price, split-adjusted to the current basis; 2.9y shown of 721 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.1% of sh out |
| Days to cover1.1d |
| 13F net flow (QoQ)+0.40% |
| Top-10 13F concentration94.8% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)1.0× |
| Sales (TTM)$12.3M |
| Earnings (TTM)$49.8M |
| Net margin434.2% |
| Sales growth 3Y−19.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+30.6% |
| 1Y−53.8% |
| Since incept. (ann.)−14.5% |
Total return through 2026-07-30 · series begins 2023-09-07. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)78.1% |
| Ann. volatility (3Y)88.1% |
| Sharpe (1Y)−0.54 |
| Sharpe (3Y)0.25 |
| Max drawdown (1Y)−79.0% |
| Max drawdown (3Y)−89.8% |
| Beta (3Y vs SPY)2.42 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| AIGH Capital Management LLC | 3.6M | $4M | 7.83% | +17.2% |
| Nantahala Capital Management, LLC | 3.2M | $3M | 6.93% | +0.0% |
| Knollwood Investment Advisory, LLC | 2.6M | $3M | 5.57% | +0.0% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.5M | $3M | 5.44% | −9.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $1M | 2.23% | new |
| PERKINS CAPITAL MANAGEMENT INC | 756,894 | $794,738 | 1.65% | −3.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 293,396 | $308,093 | 0.64% | +15.0% |
| Corient Private Wealth LLC | 249,032 | $261,484 | 0.54% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.17 | — | $3.1M | +5.5% |
| 2025-09-30 | 2025-11-06 | −$0.19 | — | $3.3M | −9.3% |
| 2025-06-30 | 2025-08-14 | −$0.26 | — | $6.3M | −0.4% |
| 2025-03-31 | 2025-05-08 | −$0.21 | — | $3.0M | −55.9% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
